Fortrea Holdings Inc.

Fortrea Holdings Inc. is a global contract research organization (CRO) that provides solutions for developing biopharmaceutical products and medical devices. The company serves pharmaceutical, biotechnology, and medical device customers. Fortrea offers clinical trial management services from Phase I through IV, clinical pharmacology, and consulting services. With over 30 years of experience, Fortrea supports customers across more than 20 therapeutic areas using agile delivery models, including Full Service, Functional Service Provider (FSP), and Hybrid structures. The company has approximately 14,300 employees and operates in approximately 100 countries. Fortrea manages its business as one reporting segment: Clinical Services. Fortrea Holdings Inc. was formed on June 29, 2023, through a spin-off of the CRO business from Labcorp Holdings Inc., becoming a standalone, publicly traded company.